Patent

Steak n Shake sees appetite for organicRestricted Content

April 12, 2014
Scott Olson
The Indianapolis-based burger chain won approval in late March from the U.S. Patent and Trademark Office to trademark the “organic signature steakburger.
More

Patent ‘troll’ label gets Congress to ponder what’s in a name

April 2, 2014
Bloomberg News
"Troll" is a term without clear definition and yet it’s being used to push Congress and the Supreme Court to curb abusive litigation. Companies including Eli Lilly warn against damaging a centuries-old system designed to promote advances in science and industry.
More

Rival's lawsuit could delay launch of new Lilly insulin

January 31, 2014
J.K. Wall
Paris-based Sanofi sued Eli Lilly and Co. on Thursday for patent infringement. That suit triggers an automatic 30-month delay on Lilly’s plans to launch a similar version of Sanofi's once-a-day insulin Lantus.
More

Dow Agro wins latest patent case involving Enlist product

October 8, 2013
 IBJ Staff
The suit, filed in January 2012 by South African-based Bayer CropScience SA, charged that Dow Agro’s Enlist E3 soybean seed infringed one of its patents.
More

Zimmer told to pay Stryker $228 million in patent case

August 8, 2013
Bloomberg News
Indiana-based Zimmer Holdings Inc., which lost a February trial against Stryker Corp. over a surgical device patent, was told to pay three times the jury award, plus other costs.
More

Delta Faucet builds innovation machine in CarmelRestricted Content

August 3, 2013
Dan Human
One of Indiana’s most innovative companies in the past decade doesn’t make surgical instruments or drugs or engines. It makes water faucets and toilets. Delta Faucet Co. has secured 589 patents in the past 20 years.
More

Dispute over vehicle 'spy' device patent flashes into court

July 3, 2013
Chris O'Malley
A Carmel company that markets a device which plugs into a car’s diagnostic port to monitor the vehicle's performance has filed a patent-infringement lawsuit against a better-known competitor.
More

High court rules against Indiana farmer in patent case

May 13, 2013
Associated Press
The Supreme Court has sustained Monsanto Co.'s claim that an Indiana farmer violated the company's patents on soybean seeds that are resistant to its weed-killer.
More

Lilly suing J&J for patent rights in Alzheimer's drug race

April 25, 2013
Bloomberg News
Eli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer’s disease.
More

Court may decide if drugmakers can pay to delay generics

March 25, 2013
Associated Press
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines.
More

High court seems to favor Monsanto in patent case

February 19, 2013
Associated Press
The U.S. Supreme Court appeared likely Tuesday to side with Monsanto Co. in its claim that an Indiana farmer violated the company's patents on soybean seeds that are resistant to its weed-killer.
More

High-stakes fight over soybeans at high court

February 18, 2013
Associated Press
The court case poses the question of an Indiana farmer's actions violated the patent rights held by Monsanto, which developed seeds that survive when farmers spray their fields with Roundup weed-killer. The seeds dominate agriculture, including in Indiana, where more than 90 percent of soybeans are Roundup Ready.
More

Hoosier colleges discover patents aren't just for faculty anymoreRestricted Content

November 10, 2012
Chris O'Malley
Universities that once focused on faculty inventions now are encouraging students to pursue patents. Last year, 355 Purdue University students filed a patent, a 62-percent jump from 218 student-filed patents the previous year.
More

Dow Agro awarded $5.3M in patent-infringement case

October 2, 2012
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products from affiliates of Dow AgroSciences violated two of its patents.
More

Dow AgroSciences prevails in patent-infringement case

September 28, 2012
The lawsuit, filed in December 2010 by Bayer CropScience SA, charged that Indianapolis-based Dow AgroSciences' herbicide-tolerance technology infringed one of its patents.
More

Lilly challenging Biogen patent in London lawsuit

January 5, 2012
Bloomberg News
Eli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system diseases.
More

Patent expirations up pressure on Lilly

December 24, 2011
Eli Lilly and Co. lost patent protection on its $5-billion-a-year best-seller Zyprexa in October, plunging the company into the long-awaited zone of uncertainty that it calls “Years YZ.”
More

JONES: Patent reform is mixed bag for life sciences companiesRestricted Content

November 26, 2011
Kristin Jones / Special to IBJ
For Indiana's life sciences sector, the change both raises hopes and creates challenges for continued growth.
More

Lilly files suit over flea medication sales from Australia

November 11, 2011
Scott Olson
The Indianapolis-based pharmaceutical firm claims an Australian veterinary clinic is infringing on its Comfortis flea medication's trademark by reselling it to U.S. consumers online.
More

BorgWarner sues Cummins over patents on turbochargers

October 27, 2011
Bloomberg News
BorgWarner Inc., the world’s biggest maker of automatic-transmission parts for vehicles, filed a lawsuit accusing Cummins Inc. of infringing on three patents for a titanium wheel used in engine turbochargers.
More

Zyprexa era comes to an end for LillyRestricted Content

October 27, 2011
 IBJ Staff
On Oct. 24, the U.S. Food and Drug Administration approved the first generic versions of Eli Lilly and Co.’s best-seller, ending 15 years of highly lucrative sales.
More

Lilly: Vendors key after Zyprexa patent loss

October 24, 2011
J.K. Wall
Lilly's patent-loss challenges—the biggest of which takes effect today—will force the company to rely even more on its 1,300 Indiana vendors.
More

Senate passes overhaul of patent system

September 10, 2011
Bloomberg News
The legislation would fundamentally alter the way patents are reviewed and mark the biggest change to U.S. patent law since at least 1952.
More

Despite sales spike, Effient has middling prospects

July 25, 2011
J.K. Wall
Remember Effient? The blood thinner that was once Eli Lilly and Co.’s greatest post-Zyprexa hope and then, after a slow launch, was dismissed as an abject failure? Well, it’s turning out to defy both predictions.
More

Lilly CEO: Immigration, tax laws slow innovation

June 23, 2011
Bloomberg News
The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More
Page  1 2 3 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. I am not by any means judging whether this is a good or bad project. It's pretty simple, the developers are not showing a hardship or need for this economic incentive. It is a vacant field, the easiest for development, and the developer already has the money to invest $26 million for construction. If they can afford that, they can afford to pay property taxes just like the rest of the residents do. As well, an average of $15/hour is an absolute joke in terms of economic development. Get in high paying jobs and maybe there's a different story. But that's the problem with this ask, it is speculative and users are just not known.

  2. Shouldn't this be a museum

  3. I don't have a problem with higher taxes, since it is obvious that our city is not adequately funded. And Ballard doesn't want to admit it, but he has increased taxes indirectly by 1) selling assets and spending the money, 2) letting now private entities increase user fees which were previously capped, 3) by spending reserves, and 4) by heavy dependence on TIFs. At the end, these are all indirect tax increases since someone will eventually have to pay for them. It's mathematics. You put property tax caps ("tax cut"), but you don't cut expenditures (justifiably so), so you increase taxes indirectly.

  4. Marijuana is the safest natural drug grown. Addiction is never physical. Marijuana health benefits are far more reaching then synthesized drugs. Abbott, Lilly, and the thousands of others create poisons and label them as medication. There is no current manufactured drug on the market that does not pose immediate and long term threat to the human anatomy. Certainly the potency of marijuana has increased by hybrids and growing techniques. However, Alcohol has been proven to destroy more families, relationships, cause more deaths and injuries in addition to the damage done to the body. Many confrontations such as domestic violence and other crimes can be attributed to alcohol. The criminal activities and injustices that surround marijuana exists because it is illegal in much of the world. If legalized throughout the world you would see a dramatic decrease in such activities and a savings to many countries for legal prosecutions, incarceration etc in regards to marijuana. It indeed can create wealth for the government by collecting taxes, creating jobs, etc.... I personally do not partake. I do hope it is legalized throughout the world.

  5. Build the resevoir. If built this will provide jobs and a reason to visit Anderson. The city needs to do something to differentiate itself from other cities in the area. Kudos to people with vision that are backing this project.

ADVERTISEMENT